Product Information
GAVILAX POWDER is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0241 per GM under NDC 43386031208. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 6, 2009.
Strength
17 g/17g
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386031208
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POLYETHYLENE GLYCOL 3350Approval Type
Generic (ANDA)
FDA Application
ANDA091077FDA Approved
10/6/2009
On Market Since
10/9/2009
Pharmacological Classes
Price Statistics
The NADAC for GAVILAX POWDER has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0241 per GM |
|---|---|
| All-time high | $0.0277 (Oct 16, 2024) |
| All-time low | $0.0207 (Nov 20, 2024) |
| 52-week high | $0.0249 |
| 52-week low | $0.0240 |
| Median price | $0.0239 |
| Average price | $0.0240 |
| Largest weekly change | -22.1% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Polyethylene Glycol 3350 market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GAVILAX POWDER?
The current National Average Drug Acquisition Cost (NADAC) for GAVILAX POWDER, manufactured by Lupin Pharmaceuticals Inc., is $0.0241 per GM (NDC 43386031208), effective Sep 30, 2026.
How has the price of GAVILAX POWDER changed over time?
Over the history we have for it, the NADAC for GAVILAX POWDER has risen 4.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GAVILAX POWDER?
Since Nov 28, 2013, the NADAC for GAVILAX POWDER has ranged from a low of $0.0207 (Nov 20, 2024) to a high of $0.0277 (Oct 16, 2024), with a median of $0.0239 per GM.
Are there cheaper alternatives to GAVILAX POWDER?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FT CLEARLAX POWDER, is $0.0142 per GM — about 41% below GAVILAX POWDER.
Who manufactures GAVILAX POWDER?
GAVILAX POWDER (NDC 43386031208) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.